These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36975382)

  • 21. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
    Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
    Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional Analysis.
    Elfadaly AN; Tsilimigras DI; Hyer JM; Paro A; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    World J Surg; 2021 Nov; 45(11):3438-3448. PubMed ID: 34341844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High tumor burden score indicated the unfavorable prognosis in patients with hepatocellular carcinoma: A meta-analysis.
    Ma W; Liu R; Wang J; Liu L; Qiu Z; Yu J; Wang W
    PLoS One; 2024; 19(8):e0308570. PubMed ID: 39116157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma.
    D'Silva M; Cho JY; Han HS; Yoon YS; Lee HW; Lee JS; Lee B; Kim M
    Surg Oncol; 2022 May; 41():101730. PubMed ID: 35231745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Models to predict disease-free survival for hepatocellular carcinoma patients with surgical resections.
    Lai Y; Lee JC; Hung HC; Cheng CH; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
    J Surg Oncol; 2020 Dec; 122(7):1444-1452. PubMed ID: 32875573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.
    Zakaria HM; Macshut M; Gaballa NK; Sherif AE; Abdel-Samea ME; Abdel-Samiee M; Marwan I; Yassein T
    Ann Med Surg (Lond); 2020 Jun; 54():47-53. PubMed ID: 32368340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma.
    Fukami Y; Saito T; Osawa T; Arikawa T; Matsumura T; Kurahashi S; Komatsu S; Kaneko K; Sano T
    Med Princ Pract; 2021; 30(2):131-137. PubMed ID: 33361696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function.
    Li Y; Ruan DY; Yi HM; Wang GY; Yang Y; Jiang N
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):477-84. PubMed ID: 26459723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
    Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.
    Conci S; Cipriani F; Donadon M; Marchitelli I; Ardito F; Famularo S; Perri P; Iaria M; Ansaloni L; Zanello M; La Barba G; Patauner S; Pinotti E; Molfino S; Germani P; Romano M; Sciannamea I; Ferrari C; Manzoni A; Troci A; Fumagalli L; Delvecchio A; Floridi A; Memeo R; Chiarelli M; Crespi M; Zimmitti G; Griseri G; Antonucci A; Zanus G; Tarchi P; Baiocchi GL; Zago M; Frena A; Ercolani G; Jovine E; Maestri M; Valle RD; Grazi GL; Romano F; Giuliante F; Torzilli G; Aldrighetti L; Ruzzenente A;
    Eur J Surg Oncol; 2022 Jan; 48(1):103-112. PubMed ID: 34325939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer.
    Grat M; Kornasiewicz O; Hołówko W; Lewandowski Z; Zieniewicz K; Paczek L; Krawczyk M
    Transplant Proc; 2013 Jun; 45(5):1899-903. PubMed ID: 23769067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade.
    Ko CC; Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
    Int J Clin Oncol; 2022 Apr; 27(4):739-748. PubMed ID: 35119581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes Mellitus and/or Nonalcoholic Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes After Hepatectomy.
    Liang J; Ariizumi SI; Nakano M; Yamamoto M
    Anticancer Res; 2019 Oct; 39(10):5639-5643. PubMed ID: 31570461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
    Zhang ZY; Zhou ZQ; Zhou GW
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
    Tian Y; Lyu H; He Y; Kanduri HK
    J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of occult hepatitis B virus infection and Torque teno virus infection and their association with hepatocellular carcinoma in chronic hepatitis C patients.
    Rosa AS; Araujo OC; Savassi-Ribas F; Fernandes CA; Coelho HS; Niel C; Villela-Nogueira CA; Araujo NM
    Virus Res; 2017 Oct; 242():166-172. PubMed ID: 28966070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.